Main > > >MACULAR DEGENERATION. *

Ophthalmo.>Dry Age-related Macular Degeneration (AMD). TREAT.: PhotoBioModulation (PBM) Therapy.
EU Approval Date: 2018. 06.22.
(*) Company; Patent APPs.; Product Na-
me & Web-Site Available on Request.
UpDate: 2018. 06.23.




Ophthalmo.>Prognostics. DNA Test.
(*) Company : ArcticDx Inc.
TradeMark: Macula Risk.
Web-Site :
arcticdx.com/macula-risk.html
UpDate: 2018. 07.04.




Ophthalmo.>Wet Age-related Macular Degeneration (AMD). Diagnostics & Monitoring. (U)
USA Approval Date: 12.28.2009.
USA Launch Date : ?
Home Use Device.
Test Duration: 3 Min. Per Eye
Test Frequency: Daily Basis
(*) Company; Patents; TradeMarks &
Web-Sites Available on Request
UpDate: 2018. 07.03.




Ophthalmo.>Wet Age-related Macular Degeneration (AMD). Monitoring. Optical Coherence Tomography (OCT) "MOBILE SELF"-Scanner. (C)
(*) Company; Patent & Web-Site Avai-
lable on Request.
UpDate: 2018. 07.05.




Ophthalmo.>Wet Age-related Macular Degeneration (AMD). Treat.: Adjunctive RadioTherapy (RT). Low Energy X-Ray Therapy. (D)
[as a one-time procedure to reduce or eliminate the need for frequent anti-vascular endothelial growth factor (anti-VEGF) injections directly into the eye, which are costly and burdensome for patients and clinicians alike]
Availability: CH; DE; GR & UK.
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2018. 07.05.




Ophthalmo.>Wet Age-related Macular Degeneration (AMD). Treat.: Aflibercept Inj. (U)
(IntraVitreal Injection)
VEGF Inhibition/Trap.
AU Approval Date : ?
CA Approval Date : 2013. 12.11.
USA Approval Date: 2011. 12.05.
USA Approval Date: 2018. 08.17.
(Once Every 3 Months)
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 08.18.




Ophthalmo.>Wet Age-related Macular Degeneration (AMD). Treat.: Pegaptanib Na Inj. (U>B)
PEGylated Aptamer RNA OligoNucleotide
VEGF Inhibition
USA Approval Date: 12.2004.
(*) Company : Bausch & Lomb Inc.
Patent : Expired
TradeMark: Macugen
UpDate: 2018. 07.04.




Ophthalmo.>Wet Age-related Macular Degeneration (AMD). Treat.: RanibizuMAb Inj. (U>G)
VEGF Inhibition
USA Approval Date: 2006. 06.30.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2018. 07.04.


>MACULAR DEGENERATION. *'s products
This section has no products